| Methisazone | |
|---|---|
|
[(1-Methyl-2-oxoindol-3-ylidene)amino]thiourea |
|
|
Other names
Metisazone |
|
| Identifiers | |
| CAS number | 1910-68-5 |
| PubChem | 6861563 |
| UNII | K3QML4J07E |
| ChEMBL | CHEMBL1512080 |
| Jmol-3D images | Image 1 |
|
|
| Properties | |
| Molecular formula | C10H10N4OS |
| Molar mass | 234.28 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Methisazone is an antiviral drug that works by inhibiting mRNA and protein synthesis, especially in pox viruses. It has been used in the past to treat smallpox.[1]
Methisazone has been described as being used in prophylaxis since at least 1965.[2][3]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)